Development of antibodies against the putative proteinase maturation protein A in relation to pneumococcal carriage and otitis media

被引:11
作者
Bogaert, D
Holmlund, E
Lahdenkari, M
de Groot, R
Kilpi, T
Hermans, PWM [1 ]
Kayhty, H
机构
[1] Erasmus MC Sophia, Pediat Lab, Rotterdam, Netherlands
[2] Natl Publ Hlth Inst, Helsinki, Finland
[3] Univ Med Ctr St Radboud, Lab Pediat Infect Dis, Nijmegen, Netherlands
来源
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY | 2006年 / 46卷 / 02期
关键词
Streptococcus pneumoniae; PpmA; acute otitis media;
D O I
10.1111/j.1574-695X.2005.00012.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The putative pneumococcal proteinase maturation protein A is a potential pneumococcal vaccine candidate. We examined serum antipneumococcal proteinase maturation protein A antibodies at 6, 12, 18 and 24 months of age, and showed that the age-related development of antipneumococcal proteinase maturation protein A antibodies is associated with pneumococcal contacts. A higher antipneumococcal proteinase maturation protein A antibody concentration at 18 months of age tends to predict for a lower risk of pneumococcal acute otitis media in the following 6 months (relative risk: 0.84, 95% confidence interval: 0.62-1.13).
引用
收藏
页码:166 / 168
页数:3
相关论文
共 10 条
[1]   Development of antibodies against pneumococcal proteins α-enolase, immunoglobulin A1 protease, streptococcal lipoprotein rotamase A, and putative proteinase maturation protein A in relation to pneumococcal carriage and Otitis Media [J].
Adrian, PV ;
Bogaert, DB ;
Oprins, M ;
Rapola, S ;
Lahdenkari, M ;
Kilpi, T ;
de Groot, R ;
Käyhty, H ;
Hermans, PWM .
VACCINE, 2004, 22 (21-22) :2737-2742
[2]  
[Anonymous], MMWR RECOMM REP
[3]   Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children [J].
Black, S ;
Shinefield, H ;
Fireman, B ;
Lewis, E ;
Ray, P ;
Hansen, JR ;
Elvin, L ;
Ensor, KM ;
Hackell, J ;
Siber, G ;
Malinoski, F ;
Madore, D ;
Chang, I ;
Kohberger, R ;
Watson, W ;
Austrian, R ;
Edwards, K .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2000, 19 (03) :187-195
[4]   Pneumococcal vaccines:: an update on current strategies [J].
Bogaert, D ;
Hermans, PWM ;
Adrian, PV ;
Rümke, HC ;
de Groot, R .
VACCINE, 2004, 22 (17-18) :2209-2220
[5]   Efficacy of a pneumococcal conjugate vaccine against acute otitis media [J].
Eskola, J ;
Kilpi, T ;
Palmu, A ;
Jokinen, J ;
Haapakoski, J ;
Herva, E ;
Takala, A ;
Käyhty, H ;
Karma, P ;
Kohberger, R ;
Siber, G ;
Mäkela, PH ;
Lockhart, S ;
Ecrola, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (06) :403-409
[6]   Bacteriology of acute otitis media in a cohort of Finnish children followed for the first two years of life [J].
Kilpi, T ;
Herva, E ;
Kaijalainen, T ;
Syrjänen, R ;
Takala, AK .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2001, 20 (07) :654-662
[7]   The putative proteinase maturation protein A of Streptococcus pneumoniae is a conserved surface protein with potential to elicit protective immune responses [J].
Overweg, K ;
Kerr, A ;
Sluijter, M ;
Jackson, MH ;
Mitchell, TJ ;
de Jong, APJM ;
de Groot, R ;
Hermans, PWM .
INFECTION AND IMMUNITY, 2000, 68 (07) :4180-4188
[8]   Anti-PsaA and the risk of pneumococcal AOM and carriage [J].
Rapola, S ;
Jäntti, V ;
Eerola, M ;
Mäkelä, PH ;
Käyhty, H ;
Kilpi, T .
VACCINE, 2003, 21 (25-26) :3608-3613
[9]   Natural development of antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A, and pneumolysin in relation to pneumococcal carriage and acute otitis media [J].
Rapola, S ;
Jäntti, V ;
Haikala, R ;
Syrjänen, R ;
Carlone, GM ;
Sampson, JS ;
Briles, DE ;
Paton, JC ;
Takala, AK ;
Kilpi, TM ;
Käyhty, H .
JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (04) :1146-1152
[10]   Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomised study [J].
Veenhoven, R ;
Bogaert, D ;
Uiterwaal, C ;
Brouwer, C ;
Kiezebrink, H ;
Bruin, J ;
IJzerman, E ;
Hermans, P ;
de Groot, R ;
Zegers, B ;
Kuis, W ;
Rijkers, G ;
Schilder, A ;
Sanders, E .
LANCET, 2003, 361 (9376) :2189-2195